Cancer Immunology, Immunotherapy,volume 53,issue 9  (09-2004)

Period of time: 2004年9期

Publisher: Springer Publishing Company

Founded in: 1976

Total resources: 35

ISSN: 0340-7004

Subject: R73 Oncology

Favorite

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Cancer Immunology, Immunotherapy,volume 53,issue 9

Menu

Immunotherapy in multiple myeloma: Id-specific strategies suggested by studies in animal models

By Corthay Alexandre,Lundin Katrin,Munthe Ludvig,Frøyland Marianne,Gedde-Dahl Tobias,Dembic Zlatko,Bogen Bjarne in (2004)

Cancer Immunology, Immunotherapy,volume 53,issue 9 , Vol. 53, Iss. 9, 2004-09 , pp. 759-769

Springer Publishing Company

Abstract Access to resources Recommend Favorite

Dendritic cells can be rapidly expanded ex vivo and safely administered in patients with metastatic breast cancer

By Dees E.,McKinnon Karen,Kuhns Jennifer,Chwastiak Kathryn,Sparks Scotty,Myers Mary,Collins Edward,Frelinger Jeffrey,Deventer Henrik,Collichio Frances,Carey Lisa,Brecher Mark,Graham Mark,Earp H.,Serody Jonathan in (2004)

Cancer Immunology, Immunotherapy,volume 53,issue 9 , Vol. 53, Iss. 9, 2004-09 , pp. 777-785

Springer Publishing Company

Abstract Access to resources Recommend Favorite

Correlation between interleukin 6 production and tumor proliferation in non-small cell lung cancer

By Yamaji Haruko,Iizasa Toshihiko,Koh Eitetsu,Suzuki Makoto,Otsuji Mizuto,Chang Hao,Motohashi Shinichiro,Yokoi Sana,Hiroshima Kenzo,Tagawa Masatoshi,Nakayama Toshinori,Fujisawa Takehiko in (2004)

Cancer Immunology, Immunotherapy,volume 53,issue 9 , Vol. 53, Iss. 9, 2004-09 , pp. 786-792

Springer Publishing Company

Abstract Access to resources Recommend Favorite

Activated vitronectin as a target for anticancer therapy with human antibodies

By Bloemendal Haiko,Boer Hetty,Koop Elianne,Dongen Alice,Goldschmeding Roel,Landman Wil,Logtenberg Ton,Gebbink Martijn,Voest Emile in (2004)

Cancer Immunology, Immunotherapy,volume 53,issue 9 , Vol. 53, Iss. 9, 2004-09 , pp. 799-808

Springer Publishing Company

Abstract Access to resources Recommend Favorite

A phase I trial of idiotypic vaccination with HMFG1 in ovarian cancer

By Nicholson Steve,Bomphray C.,Thomas H.,McIndoe A.,Barton D.,Gore M.,George Andrew in (2004)

Cancer Immunology, Immunotherapy,volume 53,issue 9 , Vol. 53, Iss. 9, 2004-09 , pp. 809-816

Springer Publishing Company

Abstract Access to resources Recommend Favorite

Proteasomal cleavage does not determine immunogenicity of gp100-derived peptides gp100209-217 and gp100209-217T210M

By Nagorsen Dirk,Servis Catherine,Lévy Nicole,Provenzano Maurizio,Dudley Mark,Marincola Francesco,Lévy Frédéric in (2004)

Cancer Immunology, Immunotherapy,volume 53,issue 9 , Vol. 53, Iss. 9, 2004-09 , pp. 817-824

Springer Publishing Company

Abstract Access to resources Recommend Favorite